References
- Nakamori Y, Park EJ, Shimaoka M. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Front Immunol. 2021;11:624279. Published 2021 Feb 17. doi:10.3389/fimmu.2020.624279
- Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions; Licence: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland, 2020; ISBN 978-92-4-001078-9
- Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
- Arefian H, Heublein S, Scherag A, et al. Hospital-related cost of sepsis: A systematic review. J Infect. 2017;74(2):107–117. doi:10.1016/j.jinf.2016.11.006
- Chen Y, Guo DZ, Zhu CL, et al. The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways. Front Immunol. 2023;14:1323797. Published 2023 Dec 13. doi:10.3389/fimmu.2023.1323797
- Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y
- Santacroce E, D’Angerio M, Ciobanu AL, et al. Advances and Challenges in Sepsis Management: Modern Tools and Future Directions. Cells. 2024;13(5):439. Published 2024 Mar 2. doi:10.3390/cells13050439
- Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019;20(21):5376. Published 2019 Oct 29. doi:10.3390/ijms20215376
- Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121–137. doi:10.1038/nrneph.2017.165
- Janssen M, Endeman H, Bos LDJ. Targeted immunomodulation: a primer for intensivists. Intensive Care Med. 2023;49(4):462–464. doi:10.1007/s00134-023-07009-8
- Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
- Patil NK, Bohannon JK, Sherwood ER. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Pharmacol Res. 2016;111:688–702. doi:10.1016/j.phrs.2016.07.019
- Zhang T, Yu-Jing L, Ma T. Role of regulation of PD-1 and PD-L1 expression in sepsis. Front Immunol. 2023;14:1029438. Published 2023 Mar 9. doi:10.3389/fimmu.2023.1029438
- Pool R, Gomez H, Kellum JA. Mechanisms of Organ Dysfunction in Sepsis. Crit Care Clin. 2018;34(1):63–80. doi:10.1016/j.ccc.2017.08.003
- Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019-results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. Published 2020 May 19. doi:10.1186/s13054-020-02950-2
- Relja B, Land WG. Damage-associated molecular patterns in trauma. Eur J Trauma Emerg Surg. 2020;46(4):751–775. doi:10.1007/s00068-019-01235-w
- Sari MI, Ilyas S. The Expression Levels and Concentrations of PD-1 and PD-L1 Proteins in Septic Patients: A Systematic Review [published correction appears in Diagnostics (Basel). 2023 Apr 26;13(9):1555. doi: 10.3390/diagnostics13091555]. Diagnostics (Basel). 2022;12(8):2004. Published 2022 Aug 19. doi:10.3390/diagnostics12082004
- Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:2050312119835043. Published 2019 Mar 21. doi:10.1177/2050312119835043
- Fu X, Liu Z, Wang Y. Advances in the Study of Immunosuppressive Mechanisms in Sepsis. J Inflamm Res. 2023;16:3967–3981. Published 2023 Sep 8. doi:10.2147/JIR.S426007
- Zhang X, Zhang Y, Yuan S, Zhang J. The potential immunological mechanisms of sepsis. Front Immunol. 2024;15:1434688. Published 2024 Jul 8. doi:10.3389/fimmu.2024.1434688
- Chen R, Qin S, Zhu H, et al. Dynamic monitoring of circulating CD8+ T and NK cell function in patients with septic shock. Immunol Lett. 2022;243:61–68. doi:10.1016/j.imlet.2022.02.004
- Wu H, Tang T, Deng H, et al. Immune checkpoint molecule Tim-3 promotes NKT cell apoptosis and predicts poorer prognosis in Sepsis. Clin Immunol. 2023;254:109249. doi:10.1016/j.clim.2023.109249
- Pelaia G, Vatrella A, Maselli R. The potential of biologics for the treatment of asthma. Nat Rev Drug Discov. 2012;11(12):958–972. doi:10.1038/nrd3792
- Chen J, Wang H, Guo R, Li H, Cui N. Early Expression of Functional Markers on CD4+ T Cells Predicts Outcomes in ICU Patients With Sepsis. Front Immunol. 2022;13:938538. Published 2022 Jul 11. doi:10.3389/fimmu.2022.938538
- Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21(1):28. Published 2022 Jan 21. doi:10.1186/s12943-021-01489-2
- Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade. Cancer Immunol Res. 2022;10(2):146–153. doi:10.1158/2326-6066.CIR-21-0515
- Qin W, Hu L, Zhang X, et al. The Diverse Function of PD-1/PD-L Pathway Beyond Cancer. Front Immunol. 2019;10:2298. Published 2019 Oct 4. doi:10.3389/fimmu.2019.02298
- Liu MY, Klement JD, Langan CJ, van Riggelen J, Liu K. Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells. Cell Immunol. 2021;366:104397. doi:10.1016/j.cellimm.2021.104397
- Dammeijer F, van Gulijk M, Mulder EE, et al. The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. Cancer Cell. 2020;38(5):685–700.e8. doi:10.1016/j.ccell.2020.09.001
- Tomino A, Tsuda M, Aoki R, et al. Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study. PLoS One. 2017;12(1):e0169653. Published 2017 Jan 10. doi:10.1371/journal.pone.0169653
- Taylor A, Harker JA, Chanthong K, Stevenson PG, Zuniga EI, Rudd CE. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses. Immunity. 2016;44(2):274–286. doi:10.1016/j.immuni.2016.01.018
- Rossi AL, Le M, Chung CS, et al. A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G106–G114. doi:10.1152/ajpgi.00204.2018
- Wang JF, Wang YP, Xie J, et al. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis. Blood. 2021;138(9):806–810. doi:10.1182/blood.2020009417
- Holub M, Džupová O, Růžková M, et al. Selected Biomarkers Correlate with the Origin and Severity of Sepsis. Mediators Inflamm. 2018;2018:7028267. Published 2018 Mar 27. doi:10.1155/2018/7028267
- Jubel JM, Barbati ZR, Burger C, Wirtz DC, Schildberg FA. The Role of PD-1 in Acute and Chronic Infection. Front Immunol. 2020;11:487. Published 2020 Mar 24. doi:10.3389/fimmu.2020.00487
- Wilson JK, Zhao Y, Singer M, Spencer J, Shankar-Hari M. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study. Crit Care. 2018;22(1):95. Published 2018 Apr 17. doi:10.1186/s13054-018-2020-2
- Ruan WS, Feng MX, Xu J, et al. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis. Front Immunol. 2020;11:1299. Published 2020 Jul 3. doi:10.3389/fimmu.2020.01299
- Jiang W, Li X, Wen M, et al. Increased percentage of PD-L1+ natural killer cells predicts poor prognosis in sepsis patients: a prospective observational cohort study. Crit Care. 2020;24(1):617. Published 2020 Oct 19. doi:10.1186/s13054-020-03329-z
- Yende S, Kellum JA, Talisa VB, et al. Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis. JAMA Netw Open. 2019;2(8):e198686. Published 2019 Aug 2. doi:10.1001/jamanetworkopen.2019.8686
- Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42(5):383–391. doi:10.1097/SHK.0000000000000234
- Francois B, Jeannet R, Daix T, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3(5):e98960. Published 2018 Mar 8. doi:10.1172/jci.insight.98960
- Chang KC, Unsinger J, Davis CG, et al. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J. 2007;21(3):708–719. doi:10.1096/fj.06-6805com
- Alpdogan O, van den Brink MR. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 2005;26(1):56–64. doi:10.1016/j.it.2004.11.002
- Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality?. J Clin Invest. 2016;126(1):23–31. doi:10.1172/JCI82224
- Venet F, Demaret J, Blaise BJ, et al. IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. J Immunol. 2017;199(5):1606–1615. doi:10.4049/jimmunol.1700127
- Barata JT, Durum SK, Seddon B. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 2019;20(12):1584–1593. doi:10.1038/s41590-019-0479-x
- Chen D, Tang TX, Deng H, Yang XP, Tang ZH. Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis. Front Immunol. 2021;12:747324. Published 2021 Dec 2. doi:10.3389/fimmu.2021.747324
- Corfe SA, Paige CJ. The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation. Semin Immunol. 2012;24(3):198–208. doi:10.1016/j.smim.2012.02.001
- Li R, Paul A, Ko KW, et al. Interleukin-7 induces recruitment of monocytes/macrophages to endothelium. Eur Heart J. 2012;33(24):3114–3123. doi:10.1093/eurheartj/ehr245
- Basheer M, Saad E, Kananeh M, et al. Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against?. Curr Issues Mol Biol. 2022;44(10):4735–4747. Published 2022 Oct 10. doi:10.3390/cimb44100323
- Venet F, Rimmelé T, Monneret G. Management of Sepsis-Induced Immunosuppression. Crit Care Clin. 2018;34(1):97–106. doi:10.1016/j.ccc.2017.08.007
- Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91–102. doi:10.1111/j.1600-065x.1997.tb01030.x
- Yu Q, Erman B, Bhandoola A, Sharrow SO, Singer A. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J Exp Med. 2003;197(4):475–487. doi:10.1084/jem.20021765
- Sammicheli S, Ruffin N, Lantto R, Vivar N, Chiodi F, Rethi B. IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells. J Autoimmun. 2012;38(4):304–314. doi:10.1016/j.jaut.2012.01.012
- Torres LK, Pickkers P, van der Poll T. Sepsis-Induced Immunosuppression. Annu Rev Physiol. 2022;84:157–181. doi:10.1146/annurev-physiol-061121-040214
- Daix T, Mathonnet A, Brakenridge S, et al. Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial. Ann Intensive Care. 2023;13(1):17. Published 2023 Mar 12. doi:10.1186/s13613-023-01109-w